Seres Therapeutics Inc (MCRB) — Cash Flow Reinvestment Rate
Seres Therapeutics Inc (MCRB) has a Cash Flow Reinvestment Rate of 0.01x as of September 2025, reinvesting $16.00K (capex $8.00K plus investments $-8.00K) from operating cash flow of $2.21 Million. Explore MCRB capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Seres Therapeutics Inc Cash Flow Reinvestment Rate (2016–2021)
Historical reinvestment intensity for Seres Therapeutics Inc across 2 annual periods. Also explore MCRB total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Seres Therapeutics Inc (2016–2021)
Year-by-year capital reinvestment analysis for Seres Therapeutics Inc. For live market cap and broader valuation context, see how much is Seres Therapeutics Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 12.44x | $83.22 Million | $6.69 Million | $9.57 Million | ▲ +733.2% |
| 2016 | 1.49x | $65.59 Million | $43.92 Million | $21.49 Million | — |